BIIB
BIOGEN INC.D4515-min delayed · EOD close220.83 −1.64% downas of 2026-09-04mkt cap $32.6B
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0000875045
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $10.3B | 2026-09-30 | 10-Q · 0000875045-26-000096 |
| Revenue (prior year) | $9.7B | 2024-12-31 | 10-K · 0000875045-25-000009 |
| Gross profit | $11.6B | 2020-12-31 | 10-K · 0000875045-21-000010 |
| Operating income | $2.5B | 2022-03-31 | 10-Q · 0000875045-22-000016 |
| Net income | $348M | 2026-09-30 | 10-Q · 0000875045-26-000096 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $32.1B | 2026-09-30 | 10-Q · 0000875045-26-000096 |
| Current assets | $7.6B | 2026-09-30 | 10-Q · 0000875045-26-000096 |